Skip to content
Learn More

Resources

iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China

July 9, 2018

NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) today announced the commencement of a strategic commercial relationship with CC-Pharming Ltd. of Beijing, China for joint development of products and manufacturing facilities for the Chinese biopharmaceutical market, utilizing iBio’s technology. The first product focus selected pursuant to the Master Joint Development Agreement …

Read More
Top